SEARCH

SEARCH BY CITATION

References

  • 1
    Tacconi MT (1998) Neuronal death: is there a role for astrocytes. Neurochem Res 23, 759765.
  • 2
    Weihong L, Pengtao L, Qian H, Jincai H, Jun W, Huan D, Tang H & Xu Y (2009) The impact of paracrine signaling in brain microvascular endothelial cells on the survival of neurons. Brain Res 1287, 2838.
  • 3
    Cohen Z, Bonvento G, Lacombe P & Hamel E (1996) Serotonin in the regulation of brain microcirculation. Prog Neurobiol 50, 335362.
  • 4
    Bondy C, Werner H, Roberts CT Jr & LeRoith D (1992) Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II. Neuroscience 46, 909923.
  • 5
    D'Ercole AJ, Stiles AD & Underwood LE (1984) Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci USA 81, 935939.
  • 6
    Lichtenwalner RJ, Forbes ME, Bennett SA, Lynch CD, Sonntag WE & Riddle DR (2001) Intracerebroventricular infusion of insulin-like growth factor-I ameliorates the age-related decline in hippocampal neurogenesis. Neuroscience 107, 603613.
  • 7
    Trejo JL, Piriz J, Llorens-Martin MV, Fernandez AM, Bolós M, LeRoith D, Nuñez A & Torres-Aleman I (2007) Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects. Mol Psychiatry 12, 1181128.
  • 8
    Kar S, Seto D, Doré S, Hanisch U & Quirion R (1997) Insulin-like growth factors-I and -II differentially regulate endogenous acetylcholine release from the rat hippocampal formation. Proc Natl Acad Sci USA 94, 1405414059.
  • 9
    Seto D, Zheng WH, McNicoll A, Collier B, Quirion R & Kar S (2002) Insulin-like growth factor-I inhibits endogenous acetylcholine release from the rat hippocampal formation: possible involvement of GABA in mediating the effects. Neuroscience 115, 603612.
  • 10
    D'Ercole AJ, Ye P, Calikoglu AS & Gutierrez-Ospina G (1996) The role of the insulin-like growth factors in the central nervous system. Mol Neurobiol 13, 227555.
  • 11
    De Smedt A, Brouns R, Uyttenboogaart M, De Raedt S, Moens M, Wilczak N, Luijckx GJ & De Keyser J (2011) Insulin-like growth factor I serum levels influence ischemic stroke outcome. Stroke 42, 21802185.
  • 12
    Denti L, Annoni V, Cattadori E, Salvagnini MA, Visioli S, Merli MF, Corradi F, Ceresini G, Valenti G, Hoffman AR et al. (2004) Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly. Am J Med 117, 312317.
  • 13
    Delafontaine P, Song YH & Li Y (2004) Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol 24, 435444.
  • 14
    Cheng HL & Feldman EL (1998) Bidirectional regulation of p38 kinase and c-Jun N-terminal protein kinase by insulin-like growth factor-I. J Biol Chem 273, 1456014565.
  • 15
    Shavali S, Ren J & Ebadi M (2003) Insulin-like growth factor-1 protects human dopaminergic SH-SY5Y cells from salsolinol-induced toxicity. Neurosci Lett 340, 7982.
  • 16
    Xing C, Peng Y, Chang R, Yin Y & Xie Z (2005) Effects of insulin-like growth factor-1 on okadaic acid-induced apoptosis in SH-SY5Y cells. Cell Biol Int 29, 803808.
  • 17
    Cao Y, Gunn AJ, Bennet L, Wu D, George S, Gluckman PD, Shao XM & Guan J (2003) Insulin-like growth factor (IGF)-1 suppresses oligodendrocyte caspase-3 activation and increases glial proliferation after ischemia in near-term fetal sheep. J Cereb Blood Flow Metab 23, 739747.
  • 18
    Guan J, Miller OT, Waugh KM, McCarthy DC & Gluckman PD (2001) Insulin-like growth factor-1 improves somatosensory function and reduces the extent of cortical infarction and ongoing neuronal loss after hypoxia–ischemia in rats. Neuroscience 105, 299306.
  • 19
    Loddick SA, Turnbull AV & Rothwell NJ (1998) Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 18, 176179.
  • 20
    Lopez-Lopez C, LeRoith D & Torres-Aleman I (2004) Insulin-like growth factor I is required for vessel remodeling in the adult brain. Proc Natl Acad Sci USA 101, 98339838.
  • 21
    Ranke MB & Elmlinger M (1997) Functional role of insulin-like growth factor binding proteins. Horm Res 48, 915.
  • 22
    Conti E, Carrozza C, Capoluongo E, Volpe M, Crea F, Zuppi C & Andreotti F (2004) Insulin-like growth factor-1 as a vascular protective factor. Circulation 110, 22602265.
  • 23
    Adams MM, Elizabeth Forbes M, Constance Linville M, Riddle DR, Sonntag WE & Brunso-Bechtold JK (2009) Stability of local brain levels of insulin-like growth factor-I in two well-characterized models of decreased plasma IGF-I. Growth Factors 27, 181188.
  • 24
    Armstrong CS, Wuarin L & Ishii DN (2000) Uptake of circulating insulin-like growth factor-I into the cerebrospinal fluid of normal and diabetic rats and normalization of IGF-II mRNA content in diabetic rat brain. J Neurosci Res 59, 649660.
  • 25
    Carro E, Spuch C, Trejo JL, Antequera D & Torres-Aleman I (2005) Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth factor I. J Neurosci 25, 1088410893.
  • 26
    Pan W & Kastin AJ (2000) Interactions of IGF-1 with the blood–brain barrier in vivo and in situ. Neuroendocrinology 72, 171178.
  • 27
    Gluckman P, Klempt N, Guan J, Mallard C, Sirimanne E, Dragunow M, Klempt M, Singh K, Williams C & Nikolics K (1992) A role for IGF-1 in the rescue of CNS neurons following hypoxic–ischemic injury. Biochem Biophys Res Commun 182, 593599.
  • 28
    Beilharz EJ, Klempt ND, Klempt M, Sirimanne E, Dragunow M & Gluckman PD (1993) Differential expression of insulin-like growth factor binding proteins (IGFBP) 4 and 5 mRNA in the rat brain after transient hypoxic–ischemic injury. Mol Brain Res 18, 209215.
  • 29
    Lee WH, Clemens JA & Bondy CA (1992) Insulin-like growth factors in the response to cerebral ischemia. Mol Cell Neurosci 3, 3643.
  • 30
    O'Donnell SL, Frederick TJ, Krady JK, Vannucci SJ & Wood TL (2002) IGF-I and microglia/macrophage proliferation in the ischemic mouse brain. Glia 39, 8597.
  • 31
    Costantini C, Lorenzetto E, Cellini B, Buffelli M, Rossi F & Della-Bianca V (2010) Astrocytes regulate the expression of insulin-like growth factor 1 receptor (IGF1-R) in primary cortical neurons during in vitro senescence. J Mol Neurosci 40, 342352.
  • 32
    Walter HJ, Berry M, Hill DJ & Logan A (1997) Spatial and temporal changes in the insulin like growth factor (IGF) axis indicate autocrine/paracrine actions of IGF-I within wounds of the rat brain. Endocrinology 138, 30243030.
  • 33
    Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR & Greenberg ME (1997) Regualtion of neuronal survival by the serinethreonine protein kinase Akt. Science 275, 661665.
  • 34
    Sun X, Yao H, Douglas RM, Wang J & Haddad GG (2010) Insulin/PI3K signaling protects dentate neruons from oxygen–glucose deprivation in organotypic slice cultures. J Neurochem 112, 377388.
  • 35
    Peruzzi F, Prisco M, Dews M, Salomoni P, Grassilli E, Romano G, Calabretta B & Baserga R (1999) Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol 19, 72037215.
  • 36
    Peruzzi F, Prisco M, Morrione A, Valentinis B & Baserga R (2001) Anti-apoptotic signaling of the IGF-1 receptor through mitochondrial translocation of c-Raf and Nedd4. J Biol Chem 276, 2599025996.
  • 37
    Sun X, Huang L, Zhang M, Sun S & Wu Y (2010) Insulin like growth factor-1 prevents 1-methyl-4-phenylphyridinium-induced apoptosis in PC12 cells through activation of glycogen synthase kinase-3 beta. Toxicology 271, 512.
  • 38
    Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Arden KC, Blenis J & Greenberg ME (1996) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857868.
  • 39
    Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J & Greenberg ME (2003) The IGF-1 receptor in cancer biology. Int J Cancer 107, 873877.
  • 40
    De Meyts P & Whittaker J (2002) Structural biology of insulin and IGF1 receptors: implications for drug design. Nat Rev Drug Discov 1, 769783.
  • 41
    Jones JI & Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16, 334.
  • 42
    Park JA, Choi KS, Kim SY & Kim KW (2003) Coordinated interaction of the vascular and nervous systems: from molecule- to cell-based approaches. Biochem Biophys Res Commun 311, 247253.
  • 43
    Longa EZ, Weinstein PR, Carlson S & Cummins R (1998) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20, 8491.
  • 44
    Jun W, Pengtao L, Huan D, Jincai H, Weihong L, Yanshu P & Chen H (2012) Tong Luo Jiu Nao injection, a traditional Chinese medicinal preparation, inhibits MIP-1β expression in brain microvascular endothelial cells injured by oxygen–glucose deprivation. J Ethnopharmacol 141, 151157.
  • 45
    Wang J, Li PT, Du H, Hou JC, Li WH, Pan YS & Chen H (2011) Impact of paracrine signals from brain microvascular endothelial cells on microglial proliferation and migration. Brain Res Bull 86, 5359.
  • 46
    Sanchez-Martin FJ, Fernandez-Salguero PM & Merino JM (2011) Aryl hydrocarbon receptor-dependent induction of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin in cerebellar granule cells from mouse. J Neurochem 118, 153162.